Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0

  • Ashish M. Kamat
  • , Joaquim Bellmunt
  • , Matthew D. Galsky
  • , Badrinath R. Konety
  • , Donald L. Lamm
  • , David Langham
  • , Cheryl T. Lee
  • , Matthew I. Milowsky
  • , Michael A. O'Donnell
  • , Peter H. O'Donnell
  • , Daniel P. Petrylak
  • , Padmanee Sharma
  • , Eila C. Skinner
  • , Guru Sonpavde
  • , John A. Taylor
  • , Prasanth Abraham
  • , Jonathan E. Rosenberg

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

After the publication of the article [1], the treatment algorithm for advanced/metastatic bladder cancer in Fig. 3 was updated to reflect the current use of immunotherapy in this setting. The correct Fig. 3 can be seen here and the original article has been updated to reflect this change.

Original languageEnglish (US)
Article number80
JournalJournal for ImmunoTherapy of Cancer
Volume5
Issue number1
DOIs
StatePublished - Sep 28 2017

Bibliographical note

Publisher Copyright:
© 2017 The Author(s).

Fingerprint

Dive into the research topics of 'Erratum: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma [Journal for Immunotherapy of Cancer., 5 (2017)(68)] DOI: 10.1186/s40425-017-0271-0'. Together they form a unique fingerprint.

Cite this